Nationwide Fund Advisors cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,527 shares of the financial services provider’s stock after selling 5,302 shares during the period. Nationwide Fund Advisors’ holdings in CME Group were worth $11,964,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Fiduciary Trust Co. bought a new position in CME Group during the 2nd quarter valued at $105,000. Whittier Trust Co. lifted its stake in CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after acquiring an additional 27 shares in the last quarter. Parallel Advisors LLC lifted its stake in CME Group by 4.1% during the 1st quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after acquiring an additional 43 shares in the last quarter. RidgeWorth Capital Management LLC lifted its stake in CME Group by 55.5% during the 1st quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $135,000 after acquiring an additional 406 shares in the last quarter. Finally, Grove Bank & Trust lifted its stake in CME Group by 41.6% during the 2nd quarter. Grove Bank & Trust now owns 1,274 shares of the financial services provider’s stock valued at $160,000 after acquiring an additional 374 shares in the last quarter. Institutional investors and hedge funds own 82.64% of the company’s stock.

In related news, President Bryan T. Durkin sold 9,200 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the completion of the sale, the president now owns 70,938 shares in the company, valued at $8,876,471.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Dennis Suskind sold 750 shares of the stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $129.34, for a total value of $97,005.00. Following the sale, the director now owns 5,059 shares of the company’s stock, valued at approximately $654,331.06. The disclosure for this sale can be found here. In the last 90 days, insiders sold 48,244 shares of company stock valued at $6,021,890. Company insiders own 0.57% of the company’s stock.

Several brokerages have weighed in on CME. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Jefferies Group LLC restated a “buy” rating and set a $134.00 price objective (up from $128.00) on shares of CME Group in a research note on Monday, July 17th. Royal Bank Of Canada raised their price objective on CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a research note on Tuesday, June 20th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, Barclays PLC started coverage on CME Group in a research report on Friday, September 8th. They set an “overweight” rating and a $139.00 target price for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $133.22.

CME Group Inc. (CME) opened at 134.17 on Monday. The firm has a 50-day moving average price of $126.73 and a 200 day moving average price of $122.14. CME Group Inc. has a 52 week low of $98.95 and a 52 week high of $134.36. The company has a market cap of $45.61 billion, a P/E ratio of 27.39 and a beta of 0.72.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. The business had revenue of $925.00 million during the quarter, compared to analysts’ expectations of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 earnings per share. Analysts expect that CME Group Inc. will post $4.82 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.

TRADEMARK VIOLATION NOTICE: “CME Group Inc. (CME) Holdings Trimmed by Nationwide Fund Advisors” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/09/25/cme-group-inc-cme-holdings-trimmed-by-nationwide-fund-advisors.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.